profit from every $100 of sales.
$0$100
Rockwell Medical
$7.03-4.74% today
+670.4% in 1 year
1-year low $0.811-year high $12.60
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Rockwell Medical sold, what it kept, and what it did with the cash.
Sales went from $72.8 million in 2022 to $69.3 million in 2025, with -$5.31 million of profit last year.
SalesProfit
Rockwell Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Rockwell Medical | No profit yet | ||
 Merck KGaA | 24.9× · Fair price | ||
 Takeda Pharmaceutical | 102.5× · Very expensive | ||
 Galderma Group | 86.9× · Very expensive | ||
 Teva Pharmaceutical Industries | 36.8× · Expensive |
AI analysis
An AI analyst reads Rockwell Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 73 | 84 | 101 | 69 | |
| 4 | 9 | 17 | 12 | |
| -17 | -7 | 1 | -5 | |
| -16 | -5 | 3 | -2 | |
| -19 | -8 | -0 | -5 | |
| -1.89 | -0.37 | -0.03 | -0.15 | |
| 5.6% | 10.4% | 17.2% | 16.9% | |
| -23.0% | -8.0% | 0.6% | -6.8% | |
| -25.7% | -10.1% | -0.5% | -7.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 47 | 52 | 59 | 57 |
| Cash | 10 | 9 | 16 | 11 |
| Total debt | – | – | – | – |
| Total liabilities | 33 | 31 | 27 | 20 |
| 14 | 21 | 33 | 37 | |
| 10 | 23 | 31 | 36 | |
| -93.8% | -22.8% | 1.9% | -9.0% | |
| -132.4% | -39.6% | -1.5% | -14.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -17 | -9 | 4 | -1 | |
| 0 | 0 | 1 | 1 | |
| -17 | -10 | 3 | -1 | |
| Dividends paid | – | – | – | – |
| 0 | – | – | – | |
| 0 | 1 | 1 | 2 |
Valuation
- –
- –
- –
- 0.9×
- 0.4×
- –
- –
- -4.3%
- -19.0%
- 0.0%
Profitability
- 16.9%
- -6.8%
- -7.7%
- -8.5%
- -2,952.1%
- -40.3%
- -4,587.8%
- -2,801.7%
- -3,119.2%
- –
Growth
- −1.7%
- –
- −137.6%
- –
- +43.3%
Financial health
- -5.4×
- 0.40
- 25.1%
- -1,313.8×
- 3.74
- 3.43
- 302.78
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 16%of 884
Bottom 14%of 886
Bottom 20%of 987
What analysts expect
- Average price target
- $3.00
- Range
- $3.00 – $3.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | -0.04 | -0.01 | −300.0% |
| Mar 26, 2026 | -0.01 | 0.04 | −125.0% |
| Nov 12, 2025 | -0.05 | -0.04 | −25.0% |
| Aug 14, 2025 | -0.05 | -0.05 | +0.0% |
| May 12, 2025 | -0.04 | -0.03 | −33.3% |
| Mar 20, 2025 | -0.02 | 0.02 | −200.0% |
| Nov 12, 2024 | 0.05 | 0.01 | +400.0% |
| Aug 8, 2024 | 0.01 | 0.00 | +125.7% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
26No pass
Benjamin Graham
65Pass
Philip Fisher
20No pass
Peter Lynch
25No pass
Joel Greenblatt
0No pass
Charlie Munger
21No pass
Terry Smith
16No pass
Questions about Rockwell Medical
Is Rockwell Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Rockwell Medical AI analysis
What does Rockwell Medical do?
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. It is in Drug Manufacturers - Specialty & Generic.
Does Rockwell Medical pay a dividend?
No. Rockwell Medical does not pay a dividend at the moment.
Is Rockwell Medical stock halal?
No. Rockwell Medical does not pass our halal screen: its cash and confirmed interest-bearing investments are 38% of its market value, at or above the 33% limit. How we check
How has Rockwell Medical stock done over the past year?
Up 670.4% over the past twelve months, to $7.03. It traded between $0.81 and $12.60 and is 44.2% below its high.
Who are Rockwell Medical's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with Rockwell Medical's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.